The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 16th Jan 2013 07:16

Anglo American: Goldman Sachs reduces target price from 1650p to 1500p and reiterates its sell recommendation.Antofagasta: Goldman Sachs ups target price from 1100p to 1120p and still recommends to sell.ARM Holdings: UBS increases target price from 750p to 900p, while downgrading to neutral.Ashtead Group: Credit Suisse raises target price from 400p to 545p retaining an outperform rating.Balfour Beatty: Credit Suisse shifts target price from 275p to 279p and keeps a neutral rating.Barclays: Nomura ups target price from 230p to 270p maintaining a reduce rating.Barratt Developments: Panmure Gordon shifts target price from 211p to 220p and retains a hold recommendation.Berendsen: Credit Suisse increases target price from 640p to 710p and maintains an outperform rating.BHP Billiton: JP Morgan takes target price from 2245p to 2300p and keeps a neutral rating. Goldman Sachs ups target price from 2400p to 2450p, while its buy recommendation remains unchanged.Brammer: Jefferies raises target price from 295p to 340p and downgrades from buy to hold.BT Group: Deutsche Bank increases target price from 235p to 269p, while retaining a hold rating.Burberry Group: UBS moves target price from 1170p to 1350p and reiterates a neutral rating. Credit Suisse ups target price from 1430p to 1550p, while staying with its outperform rating. Berenberg takes price target from 1400p to 1600p keeping a buy recommendation.Capital Shopping Centres Group: JP Morgan increases target price from 380p to 400p and upgrades to neutral.Carillion: Credit Suisse ups target price from 316p to 349p and downgrades to neutral.Centrica: Barclays raises target price from 305p to 325p and keeps an underweight rating.Charlemagne Capital: JP Morgan shifts target price from 5p to 7p, while retaining an underweight rating.COLT Telecom Group: Deutsche Bank cuts target price from 155p to 145p, while its buy recommendation is reiterated.Communisis: Panmure Gordon downgrades from buy to hold with its target price still at 47p.Diageo: Nomura lowers target price from 2070p to 2040p, while the buy rating is kept. Societe Generale reduces target price from 2050p to 1900p and downgrades to hold.Eurasian Natural Resources Corporation: JP Morgan ups target price from 275p to 300p, while the neutral rating is maintained.Fenner: Investec shifts target price from 415p to 420p, while retaining a hold rating.French Connection: Seymour Pierce cuts target price from 25p to 20p still recommending to hold.Glaxo Smith Kline: Jefferies raises target price from 1450p to 1500p and reiterates a hold rating.Home Retail Group: Barclays shifts target price from 70p to 73p and retains an underweight rating.HSBC Holdings: Nomura increases target price from 660p to 730p staying with its buy recommendation.Intermediate Capital Group: Deutsche Bank ups target price from 298p to 322p and keeps a hold rating.ITV: JP Morgan moves target price from 109p to 120p and downgrades to neutral.Kazakhmys: Goldman Sachs cuts target price from 850p to 820p, while its neutral rating is reiterated.Liontrust Asset Management: JP Morgan ups target price from 112p to 134p, while keeping an underweight rating.Lonmin: After Lonmin has not been rated, Investec recommends to hold with its target price at 353p.Lloyds Banking Group: Nomura shifts target price from 37p to 42p and maintains a reduce rating.MITIE Group: Credit Suisse reduces target price from 290p to 250p and keeps an underperform rating.N Brown: Seymour Pierce moves target price from 280p to 360p reiterating its hold recommendation.Provident Financial: JP Morgan ups target price from 1626p to 1646p, while maintaining an overweight rating.Rio Tinto: UBS reduces target price from 4340p to 4320p keeping its buy recommendation. JP Morgan raises target price from 4200p to 4400p and reiterates an overweight rating. Goldman Sachs increases target price from 3400p to 3800p, while its neutral rating remains unchanged. Deutsche Bank lowers target price from 4520p to 4450p and maintains a buy recommendation. Morgan Stanley downgrades to equalweight. Rolls-Royce Group: Credit Suisse takes price target from 850p to 900p and retains a neutral rating.Royal Bank of Scotland: Nomura raises target price from 270p to 300p and stays with a reduce rating.RPS Group: Investec moves target price from 270p to 275p keeping a buy recommendation.SAB Miller: Nomura shifts target price from 2800p to 2840p maintaining a neutral rating.Signet Jewelers: UBS ups target price from 3700p to 4050p, while its buy recommendation remains unchanged.Standart Chartered: Nomura moves target price from 1600p to 1800p reiterating a buy rating.Tarsus Group: Investec takes price target from 210p to 215p, while its buy rating in unchanged.Thorntons: Investec increases target price from 30p to 45p and stays with a hold recommendation.Virgin Media: Deutsche Bank raises target price from 2325p to 3154p, while its buy recommendation is maintained.Vodafone: Deutsche Bank cuts target price from 225p to 175p and downgrades to hold.Wetherspoon JD: Investec lowers target price from 570p to 550p and retains its buy recommendation.
More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.